Furthermore, although ALFQ showed a trend towards higher antigen-specific IgG antibody responses at weeks 26 and 56 for rectal secretions, these responses were not statistically different between the various adjuvant formulations (Fig.
← all excerpts
ALFQ adjuvanted HIV-1 envelope protein vaccination elicits durable functional antibody and cellular responses in nonhuman primates.
1
—
—